| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-06-25 |
详情>>
业绩披露：
2021年一季报每股收益-0.38元,归母净利润-1.62亿元,同比去年增长-110.66%
|
| 2021-06-25 |
详情>>
业绩披露：
2020年年报每股收益-1.02元,归母净利润-4.3亿元,同比去年增长-4.7%
|
| 2019-08-13 |
详情>>
股本变动：
变动后总股本241.63万股
|
| 2019-08-13 |
财报披露：
美东时间 2019-08-13 盘后发布财报
|
| 2019-04-30 |
股东大会：
将于2019-05-30召开股东大会
会议内容 ▼▲
- 1.To elect the Company’s five (5) nominees to hold office until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To approve an amendment to the Company’s amended and restated certificate of incorporation, if necessary, in the form attached to the proxy statement as Appendix A to effect a reverse split;
3.To approve an amendment to the Company’s 2016 Equity Incentive Plan;
4.To approve the potential issuance of in excess of 19.99% of our outstanding common stock upon the conversion of an outstanding convertible note;
5.To ratify the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
6.To transact such business as may properly come before the stockholders at the Annual Meeting.
|
| 2018-11-14 |
详情>>
业绩披露：
2018年三季报(累计)每股收益-2.01元,归母净利润-3255.7万元,同比去年增长-481.27%
|
| 2018-05-17 |
复牌提示：
2018-05-16 12:01:28 停牌，复牌日期 2018-05-16 12:06:28
|
| 2018-05-14 |
详情>>
业绩披露：
2018年一季报每股收益-0.27元,归母净利润-296万元,同比去年增长-41.15%
|
| 2018-04-30 |
股东大会：
将于2018-06-22召开股东大会
会议内容 ▼▲
- 1.To elect the Company’s six (6) nominees named in the attached proxy statement as directors to hold office until the next Annual Meeting of Stockholders or until their successors are elected and qualified;
2.To approve an amendment to our 2016 Equity Incentive Plan;
3.To approve the potential issuance of in excess of 19.99% of our outstanding common stock upon the conversion of our convertible debt facility;
4.To ratify the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018;
5.To transact such other business as may properly come before the stockholders at the Annual Meeting.
|
| 2018-03-22 |
详情>>
业绩披露：
2017年其他每股收益-0.23元,归母净利润-228.3万元,同比去年增长91.17%
|
| 2017-09-22 |
详情>>
业绩披露：
2017年年报每股收益-3.27元,归母净利润-2909.5万元,同比去年增长-56.53%
|
| 2017-03-23 |
股东大会：
将于2017-05-05召开股东大会
会议内容 ▼▲
- 1.To elect the Company’s seven (7) nominees named in the attached proxy statement as directors to hold office until the next Annual Meeting of Stockholders or until their successors are elected and qualified;
2.To approve the adoption of the Amended 2016 Equity Incentive Plan;
3.To ratify the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2017;
4.To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in this proxy statement;
5.To hold an advisory vote on the frequency of the advisory vote on executive compensation;
6.To transact such other business as may properly come before the stockholders at the Annual Meeting.
|
| 2016-03-02 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2016-01-14 |
股东大会：
将于2016-03-02召开股东大会
会议内容 ▼▲
- 1. To elect the Company’s four (4) nominees as directors to hold office until the next Annual Meeting of Stockholders or until their successors are elected and qualified;
2. To approve an amendment to the Company’s certificate of incorporation to effect a reverse split;
3. To ratify the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2016;
4. To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in this proxy statement;
5. To transact such other business as may properly come before the stockholders at the Annual Meeting.
|
| 2015-09-15 |
股东大会：
将于2015-10-30召开股东大会
会议内容 ▼▲
- 1.To approve, pursuant to Nasdaq Marketplace Rule 5635(d), of the issuance in excess of 20% of the Company’s currently outstanding shares of common stock upon the conversion of debentures and exercise of warrants to purchase shares of common stock in connection with a financing;
2.To approve an amendment to Company’s Certificate of Incorporation to increase the number of authorized shares of common stock from 150,000,000 to 350,000,000.
|
| 2015-05-11 |
股东大会：
将于2015-06-19召开股东大会
会议内容 ▼▲
- 1. To elect the Company’s five (5) nominees as directors to hold office until the next Annual Meeting of Stockholders or until their successors are elected and qualified;
2. To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of common stock from 80,000,000 shares to 150,000,000;
3. To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in this proxy statement.
|
| 2014-04-04 |
股东大会：
将于2014-04-25召开股东大会
会议内容 ▼▲
- 1. To elect six (6) directors to hold office until the next Annual Meeting of Stockholders or until their successors are elected and qualified;
2. To approve an amendment to our bylaws to clarify certain administrative functions, including changing the name to Cesca Therapeutics Inc. and providing of notice and stockholder records electronically;
3. To approve an amendment to our bylaws to allow the number of directors to be set by the board;
4. To approve an amendment to our bylaws to eliminate stockholder action by written consent;
5. To approve an amendment to our bylaws to provide for a forum for adjudication of disputes;
6. To approve amendments to the 2006 Equity Incentive Plan;
7. To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in this Proxy Statement;
8. To recommend by a non-binding advisory vote the frequency of future non-binding advisory votes on the compensation of the Company’s named executive officers;
9. To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2014 fiscal year;
10. To transact such other business as may properly come before the meeting, including adjournment.
|
| 2012-10-23 |
股东大会：
将于2012-12-07召开股东大会
会议内容 ▼▲
- 1.To elect five (5) directors to hold office until the next Annual Meeting of Stockholders or until their successors are elected and qualified
2.To approve the adoption of the 2012 Independent Director Equity Plan
3.To consider and act upon a proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2013 fiscal year
4.To transact such other business as may properly come before the meeting, including adjournment.
|
| 2011-03-10 |
详情>>
内部人交易：
ENGLE J MELVILLE股份增加22500.00股
|